Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Sensorion Reports Six-Month Update from the Audiogene Phase 1/2 Trial of SENS-501 and Advances GJB2-GT (SENS-601) Toward First-in-Human Clinical Development

Summary by Voice of Alexandria
MONTPELLIER, France--(BUSINESS WIRE)--Mar 23, 2026-
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

Voice of AlexandriaVoice of Alexandria

Sensorion Reports Six-Month Update from the Audiogene Phase 1/2 Trial of SENS-501 and Advances GJB2-GT (SENS-601) Toward First-in-Human Clinical Development

MONTPELLIER, France--(BUSINESS WIRE)--Mar 23, 2026-

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Voice of Alexandria broke the news in on Monday, March 23, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Montpellier icon

Montpellier

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal